Washed and Volume-Reduced Blood Components

Blood Banking and Transfusion Medicine

Volumn , Issue , 2007, Pages 410-418

  Sandler, S Gerald ^a,b   Johnson, Viviana V ^b   Ramasethu, Jayashree ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882501096     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06981-9.50034-X     Document Type: Chapter

References (103)

1. Circular of Information for the Use of Human Blood and Blood Components. Available at. Accessed March 29, 2006. http://www.aabb.org/Documents/About_Blood/Circulars_of_Information/coi07 02.pdf.
2. Robertson LB Transfusion of whole blood: a suggestion for its more frequent employment in war surgery. Br Med J 1917, 2:38-40.
3. Castellanos A La transfusion de globules. Arch Med Infant 1937, 6:319.
4. MacQuaide DH, Mollison PL Treatment of anaemia with concentrated red cell suspensions. Br Med J 1940, 2:555.
5. Friedberg RC, Chester A Stem cell transplantation. Transfusion Therapy: Clinical Principles and Practice 2005, 290. American Association of Blood Banks, Bethesda, Md. P.D. Mintz (Ed.).
6. Strauss RG Data-driven blood-banking practices for neonatal RBC transfusions. Transfusion 2000, 40:1528-1540.
7. Hall TL, Barnes A, Miller JR, et al. Neonatal mortality following transfusion of red cells with high plasma potassium levels. Transfusion 1993, 33:606-609.
8. Luban NL Massive transfusion in the neonate. Transfus Med Rev 1995, 9:200-214.
9. Scanlon JW, Krakaur R Hyperkalemia following exchange transfusion. J Pediatr 1980, 96:108-110.
10. Estrin JA, Belani KG, Karnavas AG, et al. A new approach to massive blood transfusion during pediatric liver resection. Surgery 1986, 99:664-670.
11. Luban NL, Strauss RF, Hume HA Commentary on the safety of red cells preserved in extended storage media for neonatal transfusions. Transfusion 1991, 31:229-235.
12. Ramirez AM, Woodfield DG, Scott R, et al. High potassium levels in stored irradiated blood [letter]. Transfusion 1987, 27:444-445.
13. Brugnara C, Churchill WH Effect of irradiation on red cell cation content and transport. Transfusion 1992, 32:246-252.
14. Davey RJ, McCoy NC, Yu M, et al. The effect of prestorage irradiation on posttransfusion red cell survival. Transfusion 1992, 32:525-528.
15. Moore GL, Ledford ME Effects of 4000 rad irradiation on the in vitro storage properties of packed red cells. Transfusion 1985, 25:583-585.
16. Standards for Blood Banks and Transfusion Services 2005, American Association of Blood Banks, Bethesda, Md. 23rd ed. M.A. Silva (Ed.).
17. Weiskopf RB, Schnapp S, Rouine-Rap K, et al. Extracellular potassium concentrations in red blood cell suspensions after irradiation and washing. Transfusion 2005, 45:1295-1301.
18. Sandler SG, Malloy D, Malamut D, et al. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995, 9:1-8.
19. Sandler SG, Eckrich R, Malamut D, et al. Hemagglutination assays for diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood 1994, 84:2031-2035.
20. Sandler SG How I manage patients suspected of having had an IgA anaphylactic transfusion reaction. Transfusion 2006, 46:10-13.
21. Rogers RL, Javed TA, Ross RE, et al. Transfusion management of an IgA deficient patient with anti-IgA and incidental correction of IgA deficiency after allogeneic bone marrow transplantation. Am J Hema-tol 1998, 57:326-330.
22. Meena-Leist CE, Fleming DR, Heye M, et al. The transfusion needs of an autologous bone marrow transplant patient with IgA deficiency. Transfusion 1999, 39:457-459.
23. Sandler SG, Yu H, Rassai N Risks of blood transfusion and their prevention. Clin Adv Hematol Oncol 2003, 1:120-124.
24. Autologous Transfusion 1983, 1-9. American Association of Blood Banks, Arlington, Va. S.G. Sandler, A.J. Silvergleid (Eds.).
25. Kruger LM, Colbert JM Intraoperative autologous transfusion in children undergoing spinal surgery. J Pediatr Orthop 1985, 5:330-332.
26. Estrin JA, Belani KG, Karnavas AG, et al. A new approach to massive blood transfusion during pediatric liver resection. Surgery 1986, 99:664-670.
27. Burman JF, Westlake AS, Davidson SJ, et al. Study of five cell salvage machines in coronary artery surgery. Transfus Med 2002, 12:173-179.
28. McShane AJ, Power C, Jackson JF, et al. Autotransfusion: quality of blood prepared with a red cell processing device. Br J Anaesth 1987, 59:1035-1039.
29. Yawn DH, Bull B Intraoperative salvage: quality of products. Autologous Blood Transfusion: Current Issues 1988, 43-55. American Association of Blood Banks, Arlington, Va. L.M. Maffei, R.L. Thurer (Eds.).
30. Boldt J, Klind D, von Bormann B, et al. Blood conservation in cardiac operations: cell separation versus hemofiltration. J Thorac Cardiovasc Surg 1989, 97:832-840.
31. Williams GD, Ramamoorthy C, Totzek FR, et al. Comparison of the effects of red cell separation and ultrafiltration on heparin concentration during pediatric cardiac surgery. J Cardiothorac Vasc Anesth 1997, 11:840-844.
32. Reents W, Babin-Ebell J, Misoph MR, et al. Influence of different auto-transfusion devices on the quality of salvaged blood. Ann Thorac Surg 1999, 68:8-62.
33. Munoz M, Garcia-Vallejo JJ, Ruiz MD, et al. Transfusion of postoperative shed blood: laboratory characteristics and clinical utility. Eur Spine J 2004, 13(Suppl 1):S107-S113.
34. Strumper EW, Weber S, Gielen-Wijffels R, et al. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion 2004, 44:1567-1571.
35. De Haan J, Boonstra PW, Monnik SH, et al. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 1995, 59:901-907.
36. Bull BS, Bull MH The salvaged blood syndrome. Blood Cells 1990, 16:5-23.
37. Ramirez G, Romero A, Garcia-Vallejo JJ, et al. Detection and removal of fat particles from postoperative salvaged blood in orthopedic surgery. Transfusion 2002, 42:66-75.
38. Van Loghem JJ, van der Hart M, Land ME Polyagglutinability of red cells as a cause of severe haemolytic transfusion reaction. Vox Sang 1955, 5:125.
39. Williams RA, Brown EF, Hurst D, et al. Transfusion of infants with activation of erythrocyte T antigen. J Pediatr 1989, 115:949-953.
40. Ramasethu J, Luban NL T activation. Br J Haematol 2001, 112:259-263.
41. Eder AF, Manno CS Does red-cell T activation matter?. Br J Haematol 2001, 114:25-30.
42. Paeker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005, 106:3699-3709.
43. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995, 333:1253-1258.
44. Smith LJ Paroxysmal nocturnal hemoglobinuria. Clin Lab Sci 2004, 17:172-177.
45. Rosse WF, Nishimura J Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems. Int J Hematol 2003, 77:113-120.
46. Hill A, Hillmen P, Richards SJ, et al. Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. Blood 2005, 106:2559-2565.
47. Dacie JV Transfusion of saline-washed red cells in nocturnal haemo-globinuria (Marchiafava-Micheli disease). Clin Sci 1947, 7:65.
48. Baranett EC, Dunlop JB, Pullar TH Chronic haemolytic anemia with paroxysmal haemoglobinuria (Marchiafava syndrome): report of a case improved by splenectomy. NZ Med J 1951, 50:39.
49. Hirsch J, Ungar B, Robinson JS Paroxysmal nocturnal haemoglobin-uria: an acquired dyshaemopoiesis. Aust Ann Med 1964, 13:24.
50. Manchester RC Chronic hemolytic anemia with paroxysmal hemo-globinuria. Ann Intern Med 1945, 23:935.
51. Brecher ME, Taswell HF Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells: a myth revisited. Transfusion 1989, 29:681.
52. Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005, 106:3699-3708.
53. Technical Manual 2005, 193. American Association of Blood Banks, Bethesda, Md. 15th ed. M.E. Brecher (Ed.).
54. Blanchette VS, Hume HA, Levy GJ, et al. Guidelines for auditing pediatric blood transfusion practices. Am J Dis Child 1991, 145:787-796.
55. Technical Manual 2005, 804. American Association of Blood Banks, Bethesda, Md. 15th ed. M.E. Brecher (Ed.).
56. Strauss RG, Villhauer PJ, Cordle DG A method to collect, store, and issue multiple aliquots of packed red blood cells for neonatal transfusions. Vox Sang 1995, 68:77-81.
57. Personal communication. RG Strauss to SG Sandler. May 15, 2003.
58. Strauss RG, Burmeister F, Johnson K, et al. AS-1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusion 1996, 36:873-878.
59. Sherwood WC, Clapper C, Wilson S The concentration of AS-1 RBCs after gravity sedimentation for neonatal transfusion. Transfusion 2000, 40:618-619.
60. Sandler SG, Ramasethu J Washed and volume-reduced components. Handbook of Pediatric Transfusion Medicine 2004, 113-120. Elsevier Academic Press, San Diego. C. Hillyer, R.G. Strauss, N.L. Luban (Eds.).
61. Skupski DW, Bussel JB Alloimmune thrombocytopenia. Clin Obstet Gynecol 1999, 42:335-348.
62. Uhrynowska M, Maslanka K, Zupanska B Neonatal thrombocytopenia: incidence, serological and clinical observations. Am J Perinatol 1997, 14:415-418.
63. McFarland JG Platelet and neutrophil alloantigen genotyping in clinical practice. Transfus Clin Biol 1998, 5:13-21.
64. Kroll H, Keifel V, Santoso S Clinical aspects and typing of platelet alloantigens. Vox Sang 1998, 74(Suppl 2):345-354.
65. Stroncek D Neonatal alloimmune neutropenia and alloimmune thrombocytopenia. Pediatric Transfusion Therapy 2002, 109-127. American Association of Blood Banks, Bethesda, Md. J.H. Herman, C.S. Manno (Eds.).
66. Bussel JB, Berkowitz RL, Lynch L, et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. Am J Obstet Gynecol 1996, 174:1414-1423.
67. Johnson JA, Ryan G, al-Musa A, et al. Prenatal diagnosis and management of neonatal alloimmune thrombocytopenia. Semin Perinatol 1997, 1:45-52.
68. Adner MM, Fisch GR, Starobin SG, et al. Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura. N Engl J Med 1969, 280:244-246.
69. Pineda AA, Zylstra VW, Clare DE, et al. Viability and functional integrity of washed platelets. Transfusion 1989, 29:524-527.
70. Ranasinghe E, Walton JD, Hurd C, et al. Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol 2001, 117:482-483.
71. Larsson L, Welsh VJ, Ladd DJ Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000, 40:902-906.
72. Pierce RN, Reich LM, Mayer K Hemolysis following platelet transfusions from ABO incompatible donors. Transfusion 1985, 25:60-62.
73. Josephson CD, Mullis NC, Van Demark C, et al. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy. Transfusion 2004, 44:805-808.
74. Schoenfeld H, Muhm M, Doepfmer U, et al. Platelet activity in washed platelet concentrates. Anesth Analg 2004, 99:17-20.
75. Mustard JF, Perry DW, Ardlie N, Packham MA Preparation of washed platelets from humans. Br J Haematol 1972, 22:193-204.
76. Silvergleid AJ, Hafleigh E, Harbin M, et al. Clinical value of washed-platelet concentrates in patients with nonhemolytic transfusion reactions. Transfusion 1977, 17:33-37.
77. Kalman ND, Brown DJ Platelet washing with a blood cell processor. Transfusion 1982, 22:125-127.
78. Smogorzewska A, Dzik W Volume-reduced apheresis platelets. Transfusion 2005, 45:651.
79. Schoenfeld H, Spies C, Jakob C Volume-reduced platelet concentrates. Curr Hematol Rep 2006, 5:82-88.
80. Moroff G, Friedman A, Robkin-Kline L, et al. Reduction of the volume of stored platelet concentrates for use in neonatal patients. Transfusion 1984, 24:144-146.
81. Holme S, Heaton WA, Moroff G, et al. Evaluation of platelet concentrates stored for 5 days with reduced plasma volume. Transfusion 1994, 34:39-43.
82. Simon TL, Sierra ER Concentration of platelet units into small volumes. Transfusion 1984, 24:173-175.
83. Strauss RG Neonatal transfusion. Scientific Basis of Transfusion Medicine: Implications for Clinical Practice 2000, 321-336. WB Saunders, Philadelphia. 2nd ed. K.C. Anderson, P.M. Ness (Eds.).
84. Strauss RG, Levy GJ, Sotelo-Avila C, et al. National survey of neonatal transfusion practices. II. Blood component therapy. Pediatrics 1993, 91:530-536.
85. Heddle NM, Klama L, Meyer R, et al. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999, 39:231-238.
86. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994, 331:625-628.
87. Muylle L, Wouters E, Peetermans ME Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996, 36:886-890.
88. Couban S, Carruthers J, Andreou P, et al. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion 2002, 42:753-758.
89. Vetlesen A, Mirlashari MR, Torsheim IA, Kjeldsen-Kragh J Platelet activation and residual activation potential storage of hyperconcen-trated platelet products in two different additive solutions. Transfusion 2005, 45:1349-1355.
90. Allen DL, Samol J, Benjamin S, et al. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization. Transfus Med 2004, 14:409-417.
91. Dumont LJ, Krailadsiiri P, Seghatchian J, et al. Preparation and storage characteristics of white cell-reduced platelet concentrates collected by an apheresis system for transfusions in utero. Transfusion 2000, 40:91-100.
92. Dumont LJ, Beddard R, Whitley P, et al. Autologous transfusion recovery of WBC-reduced high-concentration platelet concentrates. Transfusion 2002, 42:1333-1339.
93. Rinder HM, Snyder EL, Tracey JB, et al. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 2003, 43:1230-1237.
94. Simon TL, Sierra ER Concentration of platelet units into small volumes. Transfusion 1984, 24:173-175.
95. Pisciotto PT, Snyder EL, Napychank PA, et al. In vitro characteristics of volume-reduced platelet concentrate stored in syringes. Transfusion 1991, 31:404-408.
96. Ali AM, Warkentin TE, Bardossy L, et al. Platelet concentrates stored for 5 days in a reduced volume of plasma maintain hemostatic function and viability. Transfusion 1994, 34:44-47.
97. Rock G, Haddad SA, Poon AO, et al. Reduction of plasma volume after storage of platelets in CP2D. Transfusion 1998, 38:242-246.
98. Zilber M, Friedman Z, Shapiro H, et al. The effect of plasma depletion of platelet concentrates on platelet aggregation and phosphatidylser-ine expression. Clin Appl Thromb Hemost 2003, 9:39-44.
99. Shoenfeld H, Muhm M, Doepfmer UR, et al. The functional integrity of platelets in volume-reduced platelet concentrates. Anesth Analg 2005, 100:78-81.
100. Ringwald J, Walz S, Zimmermann R, et al. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality. Vox Sang 2005, 89:11-18.
101. Isola H, Kientz D, Aleil B, et al. In vitro evaluation of Haemaonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set. Vox Sang 2006, 90:128-130.
102. Janetzko K, Lin L, Eichler H, et al. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets. Vox Sang 2004, 86:239-245.
103. Gulliksson H Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003, 17:209-215.